Ethical issues in Alzheimer’s disease: an overview

References

• Fisk JD, Sadovnick AD, Cohen CA et al. Ethical guidelines of the Alzheimer Society of Canada. Can. J. Neurol. Sci.25(3), 242–248 (1998).
   PubMed Web of Science ®Google Scholar
• Post SG, Whitehouse PJ. Fairhill guidelines on ethics of the care of people with Alzheimer’s disease: a clinical summary. Center for Biomedical Ethics, Case Western Reserve University and the Alzheimer’s Association. J. Am. Geriatr. Soc.43(12), 1423–1429 (1995).
   PubMed Web of Science ®Google Scholar
• Carpenter B, Dave J. Disclosing a dementia diagnosis: a review of opinion and practice, and a proposed research agenda. Gerontologist44(2), 149–158 (2004).
   PubMed Web of Science ®Google Scholar
• Black JS. Telling the truth: should persons with Alzheimer’s disease be told their diagnosis? Alzheimer’s Disease International Global Perspective6, 10–11 (1995).
   Google Scholar
• Marzanski M. On telling the truth to patients with dementia. West. J. Med.173(5), 318–323 (2000).
   PubMedGoogle Scholar
• Bamford C, Lamont S, Eccles M, Robinson L, May C, Bond J. Disclosing a diagnosis of dementia: a systematic review. Int. J. Geriatr. Psychiatry19(2), 151–169 (2004).
   PubMed Web of Science ®Google Scholar
• Dubois B, Feldman HH, Jacova C et al. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS–ADRDA criteria. Lancet Neurol.6(8), 734–746 (2007).
   PubMed Web of Science ®Google Scholar
• Beauchamp TL, Childress JF. Principles of Biomedical Ethics. Oxford University Press, Oxford, UK (2001).
   Google Scholar
• Porteri C, Galluzzi S, Geroldi C, Frisoni GB. Diagnosis disclosure of prodromal Alzheimer disease – ethical analysis of two cases. Can. J. Neurol. Sci.37(1), 67–75 (2010).
   PubMed Web of Science ®Google Scholar
• Pinner G. Truth-telling and the diagnosis of dementia. Br. J. Psychiatry176, 514–515 (2000).
   PubMed Web of Science ®Google Scholar
• McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS–ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology34(7), 939–944 (1984).
   PubMed Web of Science ®Google Scholar
• McKhann GM, Knopman DS, Chertkow H et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging–Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement.7(3), 263–269 (2011).
   PubMed Web of Science ®Google Scholar
• Albert MS, DeKosky ST, Dickson D et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging–Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement.7(3), 270–279 (2011).
   PubMed Web of Science ®Google Scholar
• Sperling RA, Aisen PS, Beckett LA et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging–Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement.7(3), 280–292 (2011).
   PubMed Web of Science ®Google Scholar
• Davis DG, Schmitt FA, Wekstein DR, Markesbery WR. Alzheimer neuropathologic alterations in aged cognitively normal subjects. J. Neuropathol. Exp. Neurol.58(4), 376–388 (1999).
   PubMed Web of Science ®Google Scholar
• Knopman DS, Parisi JE, Salviati A et al. Neuropathology of cognitively normal elderly. J. Neuropathol. Exp. Neurol.62(11), 1087–1095 (2003).
   PubMed Web of Science ®Google Scholar
• Rabinovici GD, Jagust WJ, Furst AJ et al. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann. Neurol.64(4), 388–401 (2008).
   PubMed Web of Science ®Google Scholar
• Tang-Wai DF, Graff-Radford NR, Boeve BF et al. Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology63(7), 1168–1174 (2004).
   PubMed Web of Science ®Google Scholar
• Jack CR Jr, Knopman DS, Jagust WJ et al. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol.9(1), 119–128 (2010).
   PubMed Web of Science ®Google Scholar
• Mormino EC, Kluth JT, Madison CM et al. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain132(Pt 5), 1310–1323 (2009).
   PubMed Web of Science ®Google Scholar
• Perrin RJ, Fagan AM, Holtzman DM. Multimodal techniques for diagnosis and prognosis of Alzheimer’s disease. Nature461(7266), 916–922 (2009).
   PubMed Web of Science ®Google Scholar
• Jack CR Jr, Lowe VJ, Weigand SD et al. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer’s disease: implications for sequence of pathological events in Alzheimer’s disease. Brain132(Pt 5), 1355–1365 (2009).
   PubMed Web of Science ®Google Scholar
• Karlawish J. Addressing the ethical, policy, and social challenges of preclinical Alzheimer disease. Neurology77(15), 1487–1493 (2011).
   PubMed Web of Science ®Google Scholar
• Green RC, Roberts JS, Cupples LA et al. Disclosure of APOE genotype for risk of Alzheimer’s disease. N. Engl. J. Med.361(3), 245–254 (2009).
   PubMed Web of Science ®Google Scholar
• Gordon SC, Landa D. Disclosure of the genetic risk of Alzheimer’s disease. N. Engl. J. Med.362(2), 181–182; author reply 182 (2010).
   PubMed Web of Science ®Google Scholar
• Gauthier S, Patterson C, Gordon M, Soucy JP, Schubert F, Leuzy A. Commentary on ‘Recommendations from the National Institute on Aging–Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease.’ A Canadian perspective. Alzheimers Dement.7(3), 330–332 (2011).
   PubMed Web of Science ®Google Scholar
• Draper B, Peisah C, Snowdon J, Brodaty H. Early dementia diagnosis and the risk of suicide and euthanasia. Alzheimers Dement.6(1), 75–82 (2010).
   PubMed Web of Science ®Google Scholar
• van der Cammen TJ, Croes EA, Dermaut B et al. Genetic testing has no place as a routine diagnostic test in sporadic and familial cases of Alzheimer’s disease. J. Am. Geriatr. Soc.52(12), 2110–2113 (2004).
   PubMed Web of Science ®Google Scholar
• Burger PC, Vogel FS. The development of the pathologic changes of Alzheimer’s disease and senile dementia in patients with Down’s syndrome. Am. J. Pathol.73(2), 457–476 (1973).
   PubMed Web of Science ®Google Scholar
• Roses AD. A model for susceptibility polymorphisms for complex diseases: apolipoprotein E and Alzheimer disease. Neurogenetics1(1), 3–11 (1997).
   PubMed Web of Science ®Google Scholar
• Olgiati P, Politis AM, Papadimitriou GN, De Ronchi D, Serretti A. Genetics of late-onset Alzheimer’s disease: update from the Alzgene database and analysis of shared pathways. Int. J. Alzheimers Dis.2011, 832379 (2011).
   PubMedGoogle Scholar
• Guerreiro RJ, Gustafson DR, Hardy J. The genetic architecture of Alzheimer’s disease: beyond APP, PSENs and APOE. Neurobiol. Aging33(3), 437–456 (2012).
   PubMed Web of Science ®Google Scholar
• Bateman RJ, Aisen PS, De Strooper B et al. Autosomal-dominant Alzheimer’s disease: a review and proposal for the prevention of Alzheimer’s disease. Alzheimers Res. Ther.3(1), 1 (2011).
   PubMed Web of Science ®Google Scholar
• Green EK, Thaker U, Mcdonagh AM et al. A polymorphism within intron 11 of the tau gene is not increased in frequency in patients with sporadic Alzheimer’s disease, nor does it influence the extent of tau pathology in the brain. Neurosci. Lett.324(2), 113–116 (2002).
   PubMed Web of Science ®Google Scholar
• Evans JP, Skrzynia C, Burke W. The complexities of predictive genetic testing. BMJ322(7293), 1052–1056 (2001).
   PubMed Web of Science ®Google Scholar
• Campion D, Dumanchin C, Hannequin D et al. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am. J. Hum. Genet.65(3), 664–670 (1999).
   PubMed Web of Science ®Google Scholar
• McConnell LM, Koenig BA, Greely HT, Raffin TA. Genetic testing and Alzheimer disease: has the time come? Alzheimer Disease Working Group of the Stanford Program in Genomics, Ethics & Society. Nat. Med.4(7), 757–759 (1998).
   PubMed Web of Science ®Google Scholar
• Bird TD. Genetic aspects of Alzheimer disease. Genet. Med.10(4), 231–239 (2008).
   PubMed Web of Science ®Google Scholar
• Tibben A, Stevens M, De Wert GM, Niermeijer MF, Van Duijn CM, Van Swieten JC. Preparing for presymptomatic DNA testing for early onset Alzheimer’s disease/cerebral haemorrhage and hereditary Pick disease. J. Med. Genet.34(1), 63–72 (1997).
   PubMed Web of Science ®Google Scholar
• Kane RA, Kane RL. Effect of genetic testing for risk of Alzheimer’s disease. N. Engl. J. Med.361(3), 298–299 (2009).
   PubMed Web of Science ®Google Scholar
• Neumann PJ, Hammitt JK, Mueller C et al. Public attitudes about genetic testing for Alzheimer’s disease. Health Aff. (Millwood)20(5), 252–264 (2001).
   PubMed Web of Science ®Google Scholar
• Massoud F, Gauthier S. Update on the pharmacological treatment of Alzheimer’s disease. Curr. Neuropharmacol.8(1), 69–80 (2010).
   PubMed Web of Science ®Google Scholar
• Lopez OL, Becker JT, Wahed AS et al. Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease. J. Neurol. Neurosurg. Psychiatry80(6), 600–607 (2009).
   PubMed Web of Science ®Google Scholar
• Miller FG, Brody H. What makes placebo-controlled trials unethical? Am. J. Bioeth.2(2), 3–9 (2002).
   PubMed Web of Science ®Google Scholar
• Freedman B, Glass KC, Weijer C. Placebo orthodoxy in clinical research. II: ethical, legal, and regulatory myths. J. Law Med. Ethics24(3), 252–259 (1996).
   PubMed Web of Science ®Google Scholar
• Rockwood K. Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer’s disease. J. Neurol. Neurosurg. Psychiatry75(5), 677–685 (2004).
   PubMed Web of Science ®Google Scholar
• Karlawish JH, Whitehouse PJ. Is the placebo control obsolete in a world after donepezil and vitamin E? Arch. Neurol.55(11), 1420–1424 (1998).
   PubMedGoogle Scholar
• Leber PD. Hazards of inference: the active control investigation. Epilepsia30(Suppl. 1), S57–S63; discussion S64–S58 (1989).
   PubMed Web of Science ®Google Scholar
• Kawas CH, Clark CM, Farlow MR et al. Clinical trials in Alzheimer disease: debate on the use of placebo controls. Alzheimer Dis. Assoc. Disord.13(3), 124–129 (1999).
   PubMed Web of Science ®Google Scholar
• Farlow MR. New treatments in Alzheimer disease and the continued need for placebo-controlled trials. Arch. Neurol.55(11), 1396–1398 (1998).
   PubMed Web of Science ®Google Scholar
• Donnelly RE, Karlinsky H. The impact of Alzheimer’s disease on driving ability: a review. J. Geriatr. Psychiatry Neurol.3(2), 67–72 (1990).
   PubMedGoogle Scholar
• Man-Son-Hing M, Marshall SC, Molnar FJ, Wilson KG. Systematic review of driving risk and the efficacy of compensatory strategies in persons with dementia. J. Am. Geriatr. Soc.55(6), 878–884 (2007).
   PubMed Web of Science ®Google Scholar
• Friedland RP, Koss E, Kumar A et al. Motor vehicle crashes in dementia of the Alzheimer type. Ann. Neurol.24(6), 782–786 (1988).
   PubMed Web of Science ®Google Scholar
• Lucas-Blaustein MJ, Filipp L, Dungan C, Tune L. Driving in patients with dementia. J. Am. Geriatr. Soc.36(12), 1087–1091 (1988).
   PubMed Web of Science ®Google Scholar
• Carr DB, Duchek J, Morris JC. Characteristics of motor vehicle crashes of drivers with dementia of the Alzheimer type. J. Am. Geriatr. Soc.48(1), 18–22 (2000).
   PubMed Web of Science ®Google Scholar
• O’Brien HL, Tetewsky SJ, Avery LM, Cushman LA, Makous W, Duffy CJ. Visual mechanisms of spatial disorientation in Alzheimer’s disease. Cereb. Cortex11(11), 1083–1092 (2001).
   PubMed Web of Science ®Google Scholar
• Carr DB, Labarge E, Dunnigan K, Storandt M. Differentiating drivers with dementia of the Alzheimer type from healthy older persons with a traffic sign naming test. J. Gerontol. A Biol. Sci. Med. Sci.53(2), M135–M139 (1998).
   PubMed Web of Science ®Google Scholar
• Duchek JM, Carr DB, Hunt L et al. Longitudinal driving performance in early-stage dementia of the Alzheimer type. J. Am. Geriatr. Soc.51(10), 1342–1347 (2003).
   PubMed Web of Science ®Google Scholar
• Uc EY, Rizzo M, Anderson SW, Shi Q, Dawson JD. Driver landmark and traffic sign identification in early Alzheimer’s disease. J. Neurol. Neurosurg. Psychiatry76(6), 764–768 (2005).
   PubMed Web of Science ®Google Scholar
• Alterra A. The Caregiver: a Life with Alzheimer’s. UBC Press, Vancouver, Canada (2007).
   Google Scholar
• Taylor BD, Tripodes S. The effects of driving cessation on the elderly with dementia and their caregivers. Accid. Anal. Prev.33(4), 519–528 (2001).
   PubMed Web of Science ®Google Scholar
• Brown LB, Ott BR. Driving and dementia: a review of the literature. J. Geriatr. Psychiatry Neurol.17(4), 232–240 (2004).
   PubMed Web of Science ®Google Scholar
• Rizzo M, Reinach S, Mcgehee D, Dawson J. Simulated car crashes and crash predictors in drivers with Alzheimer disease. Arch. Neurol.54(5), 545–551 (1997).
   PubMed Web of Science ®Google Scholar
• Smith GE, Ivnik RJ, Malec JF, Kokmen E, Tangalos E, Petersen RC. Psychometric properties of the Mattis Dementia Rating Scale. Assessment1(2), 123–132 (1994).
   PubMedGoogle Scholar
• Drachman DA, Swearer JM. Driving and Alzheimer’s disease: the risk of crashes. Neurology43(12), 2448–2456 (1993).
   PubMed Web of Science ®Google Scholar
• Brashear A, Unverzagt FW, Kuhn ER, Perkins AJ, Farlow MR, Hui SL. Simple office tools to predict impaired drivers with dementia. Neurology58(7), A275–A276 (2002).
   Google Scholar
• Dubinsky RM, Stein AC, Lyons K. Practice parameter: risk of driving and Alzheimer’s disease (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology. Neurology54(12), 2205–2211 (2000).
   PubMed Web of Science ®Google Scholar
• Odenheimer GL, Beaudet M, Jette AM, Albert MS, Grande L, Minaker KL. Performance-based driving evaluation of the elderly driver: safety, reliability, and validity. J. Gerontol.49(4), M153–M159 (1994).
   PubMedGoogle Scholar
• Hunt LA, Murphy CF, Carr D, Duchek JM, Buckles V, Morris JC. Reliability of the Washington University Road Test. A performance-based assessment for drivers with dementia of the Alzheimer type. Arch. Neurol.54(6), 707–712 (1997).
   PubMed Web of Science ®Google Scholar
• Dawson JD, Anderson SW, Uc EY, Dastrup E, Rizzo M. Predictors of driving safety in early Alzheimer disease. Neurology72(6), 521–527 (2009).
   PubMed Web of Science ®Google Scholar
• Ball K, Owsley C, Sloane ME, Roenker DL, Bruni JR. Visual attention problems as a predictor of vehicle crashes in older drivers. Invest. Ophthalmol. Vis. Sci.34(11), 3110–3123 (1993).
   PubMed Web of Science ®Google Scholar
• Owsley C, Ball K, Sloane ME, Roenker DL, Bruni JR. Visual/cognitive correlates of vehicle accidents in older drivers. Psychol. Aging6(3), 403–415 (1991).
   PubMed Web of Science ®Google Scholar
• Kapust LR, Weintraub S. To drive or not to drive: preliminary results from road testing of patients with dementia. J. Geriatr. Psychiatry Neurol.5(4), 210–216 (1992).
   PubMedGoogle Scholar
• Adler G, Rottunda SJ. The driver with dementia: a survey of physician attitudes, knowledge, and practice. Am. J. Alzheimers Dis. Other Demen.26(1), 58–64 (2011).
   PubMed Web of Science ®Google Scholar
• Tinetti ME, Liu WL, Ginter SF. Mechanical restraint use and fall-related injuries among residents of skilled nursing facilities. Ann. Intern. Med.116(5), 369–374 (1992).
   PubMed Web of Science ®Google Scholar
• Evans LK, Strumpf NE. Myths about elder restraint. Image J. Nurs. Sch.22(2), 124–128 (1990).
   PubMedGoogle Scholar
• Sullivan-Marx EM. Achieving restraint-free care of acutely confused older adults. J. Gerontol. Nurs.27(4), 56–61 (2001).
   PubMedGoogle Scholar
• Miles SH, Irvine P. Deaths caused by physical restraints. Gerontologist32(6), 762–766 (1992).
   PubMed Web of Science ®Google Scholar
• Marcy-Edwards D. Bed rails. Is there an up side? Can. Nurse101(1), 30–34 (2005).
   PubMedGoogle Scholar
• Luo H, Lin M, Castle N. Physical restraint use and falls in nursing homes: a comparison between residents with and without dementia. Am. J. Alzheimers Dis. Other Demen.26(1), 44–50 (2011).
   PubMed Web of Science ®Google Scholar
• Bredthauer D, Becker C, Eichner B, Koczy P, Nikolaus T. Factors relating to the use of physical restraints in psychogeriatric care: a paradigm for elder abuse. Z. Gerontol. Geriatr.38(1), 10–18 (2005).
   PubMed Web of Science ®Google Scholar
• Catchen H. Repeaters: inpatient accidents among the hospitalized elderly. Gerontologist23(3), 273–276 (1983).
   PubMedGoogle Scholar
• Coyle N. Cancer audit. A problem-focused approach to nursing audit: patient falls. Cancer Nurs.2(5), 389–391 (1979).
   PubMedGoogle Scholar
• Feist RR. A survey of accidental falls in a small home for the aged. J. Gerontol. Nurs.4(6), 15–17 (1978).
   PubMedGoogle Scholar
• Rainville NG. Effect of an implemented fall prevention program on the frequency of patient falls. QRB Qual. Rev. Bull.10(9), 287–291 (1984).
   PubMedGoogle Scholar
• Strumpf NE, Evans LK. Physical restraint of the hospitalized elderly: perceptions of patients and nurses. Nurs. Res.37(3), 132–137 (1988).
   PubMed Web of Science ®Google Scholar
• Cotter VT. The burden of dementia. Am. J. Manag. Care13(Suppl. 8), S193–S197 (2007).
   PubMed Web of Science ®Google Scholar
• Mion LC, Frengley JD, Jakovcic CA, Marino JA. A further exploration of the use of physical restraints in hospitalized patients. J. Am. Geriatr. Soc.37(10), 949–956 (1989).
   PubMed Web of Science ®Google Scholar
• Hamers JP, Huizing AR. Why do we use physical restraints in the elderly? Z. Gerontol. Geriatr.38(1), 19–25 (2005).
   PubMed Web of Science ®Google Scholar
• Cohen-Mansfield J. Nonpharmacologic interventions for inappropriate behaviors in dementia: a review, summary, and critique. Am. J. Geriatr. Psychiatry9(4), 361–381 (2001).
   PubMed Web of Science ®Google Scholar
• Goldman BD. Commentary: barriers to a sustained restraint-free environment. J. Aging Soc. Policy20(3), 286–294 (2008).
   PubMed Web of Science ®Google Scholar
• Aminoff BZ, Adunsky A. Dying dementia patients: too much suffering, too little palliation. Am. J. Hosp. Palliat. Care22(5), 344–348 (2005).
   PubMedGoogle Scholar
• Morrison RS, Meier DE. Clinical practice. Palliative care. N. Engl. J. Med.350(25), 2582–2590 (2004).
   PubMed Web of Science ®Google Scholar
• Aminoff BZ. Overprotection phenomenon with dying dementia patients. Am. J. Hosp. Palliat. Care22(4), 247–248 (2005).
   PubMedGoogle Scholar
• Evers MM, Purohit D, Perl D, Khan K, Marin DB. Palliative and aggressive end-of-life care for patients with dementia. Psychiatr. Serv.53(5), 609–613 (2002).
   PubMed Web of Science ®Google Scholar
• Finucane TE, Christmas C, Travis K. Tube feeding in patients with advanced dementia: a review of the evidence. JAMA282(14), 1365–1370 (1999).
   PubMed Web of Science ®Google Scholar
• Mann UM, Mohr E, Gearing M, Chase TN. Heterogeneity in Alzheimer’s disease: progression rate segregated by distinct neuropsychological and cerebral metabolic profiles. J. Neurol. Neurosurg. Psychiatry55(10), 956–959 (1992).
   PubMed Web of Science ®Google Scholar
• Gjerdingen DK, Neff JA, Wang M, Chaloner K. Older persons’ opinions about life-sustaining procedures in the face of dementia. Arch. Fam. Med.8(5), 421–425 (1999).
   PubMedGoogle Scholar
• Heap MJ, Munglani R, Klinck JR, Males AG. Elderly patients’ preferences concerning life-support treatment. Anaesthesia48(12), 1027–1033 (1993).
   PubMed Web of Science ®Google Scholar
• Adunsky A, Zvi Aminoff B, Arad M, Bercovitch M. Mini-suffering state examination: suffering and survival of end-of-life cancer patients in a hospice setting. Am. J. Hosp. Palliat. Care24(6), 493–498 (2007).
   PubMedGoogle Scholar
• Mitchell SL, Kiely DK, Hamel MB, Park PS, Morris JN, Fries BE. Estimating prognosis for nursing home residents with advanced dementia. JAMA291(22), 2734–2740 (2004).
   PubMed Web of Science ®Google Scholar
• Villanueva MR, Smith TL, Erickson JS, Lee AC, Singer CM. Pain Assessment for the Dementing Elderly (PADE): reliability and validity of a new measure. J. Am. Med. Dir. Assoc.4(1), 1–8 (2003).
   PubMedGoogle Scholar
• Gauthier S, Panisset M. Current diagnostic methods and outcome variables for clinical investigation of Alzheimer’s disease. J. Neural. Transm. Suppl.53, 251–254 (1998).
   PubMedGoogle Scholar
• Fowler FJ Jr, Coppola KM, Teno JM. Methodological challenges for measuring quality of care at the end of life. J. Pain Symptom Manage.17(2), 114–119 (1999).
   PubMed Web of Science ®Google Scholar
• Dresser R, Whitehouse PJ. The incompetent patient on the slippery slope. Hastings Cent. Rep.24(4), 6–12 (1994).
   PubMed Web of Science ®Google Scholar
• Karlawish JH, Quill T, Meier DE. A consensus-based approach to providing palliative care to patients who lack decision-making capacity. ACP–ASIM End-of-Life Care Consensus Panel. American College of Physicians–American Society of Internal Medicine. Ann. Intern. Med.130(10), 835–840 (1999).
   PubMed Web of Science ®Google Scholar
• Thies W, Bleiler L. 2011 Alzheimer’s disease facts and figures. Alzheimers Dement.7(2), 208–244 (2011).
   PubMed Web of Science ®Google Scholar
• Post SG, Ripich DN, Whitehouse PJ. Discourse ethics: research, dementia, and communication. Alzheimer Dis. Assoc. Disord.8(Suppl. 4), 58–65 (1994).
   PubMed Web of Science ®Google Scholar